0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Wearable Continuous Glucose Monitoring System Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-27T16726
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Wearable Continuous Glucose Monitoring System Market Research Report 2024
BUY CHAPTERS

Global Wearable Continuous Glucose Monitoring System Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-27T16726
Report
November 2025
Pages:144
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Wearable Continuous Glucose Monitoring System Market

The global Wearable Continuous Glucose Monitoring System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
A Wearable Continuous Glucose Monitoring System (CGMS) is a device worn by individuals with diabetes that continuously measures and tracks the levels of glucose in their bloodstream. This system typically consists of a sensor placed under the skin, which detects glucose levels through interstitial fluid. The data is transmitted to a receiver, smartphone app, or smartwatch, allowing patients and healthcare providers to monitor blood sugar levels in real-time and receive alerts for potential hypo- or hyperglycemic events.
From a downstream perspective, On-Line accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Wearable Continuous Glucose Monitoring System leading manufacturers including Dexcom, Abbott, Medtronic, Senseonics Holdings, Handan Meiqi Medical Technology, San Meditech, etc., dominate supply; the top five capture approximately % of global revenue, with Dexcom leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Wearable Continuous Glucose Monitoring System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Sales Channel, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Wearable Continuous Glucose Monitoring System Market Report

Report Metric Details
Report Name Wearable Continuous Glucose Monitoring System Market
Segment by Type
  • SMD Type
  • Watch Type
  • Others
Segment by Sales Channel
  • On-Line
  • Offline
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Dexcom, Abbott, Medtronic, Senseonics Holdings, Handan Meiqi Medical Technology, San Meditech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Wearable Continuous Glucose Monitoring System study scope, segments the market by Type and by Sales Channel, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Sales Channel, identifies emerging use cases, and profiles leading customers by region and by Sales Channel.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Sales Channel and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Sales Channel and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Sales Channel, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Sales Channel, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Sales Channel, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Sales Channel, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Wearable Continuous Glucose Monitoring System Market report?

Ans: The main players in the Wearable Continuous Glucose Monitoring System Market are Dexcom, Abbott, Medtronic, Senseonics Holdings, Handan Meiqi Medical Technology, San Meditech

What are the Type segmentation covered in the Wearable Continuous Glucose Monitoring System Market report?

Ans: The Types covered in the Wearable Continuous Glucose Monitoring System Market report are SMD Type, Watch Type, Others

1 Study Coverage
1.1 Introduction to Wearable Continuous Glucose Monitoring System: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Wearable Continuous Glucose Monitoring System Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 SMD Type
1.2.3 Watch Type
1.2.4 Others
1.3 Market Segmentation by Sales Channel
1.3.1 Global Wearable Continuous Glucose Monitoring System Market Size by Sales Channel, 2020 VS 2024 VS 2031
1.3.2 On-Line
1.3.3 Offline
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Wearable Continuous Glucose Monitoring System Revenue Estimates and Forecasts 2020-2031
2.2 Global Wearable Continuous Glucose Monitoring System Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Wearable Continuous Glucose Monitoring System Sales Estimates and Forecasts 2020-2031
2.4 Global Wearable Continuous Glucose Monitoring System Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Wearable Continuous Glucose Monitoring System Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Wearable Continuous Glucose Monitoring System Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 SMD Type Market Size by Manufacturers
3.5.2 Watch Type Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Wearable Continuous Glucose Monitoring System Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Wearable Continuous Glucose Monitoring System Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Wearable Continuous Glucose Monitoring System Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Wearable Continuous Glucose Monitoring System Sales by Sales Channel
5.1.1 Global Historical and Forecasted Sales by Sales Channel (2020-2031)
5.1.2 Global Sales Market Share by Sales Channel (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Wearable Continuous Glucose Monitoring System Revenue by Sales Channel
5.2.1 Global Historical and Forecasted Revenue by Sales Channel (2020-2031)
5.2.2 Revenue Market Share by Sales Channel (2020-2031)
5.3 Global Pricing Dynamics by Sales Channel (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Sales Channel
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Wearable Continuous Glucose Monitoring System Sales and Revenue by Type (2020-2031)
6.4 North America Wearable Continuous Glucose Monitoring System Sales and Revenue by Sales Channel (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Wearable Continuous Glucose Monitoring System Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Wearable Continuous Glucose Monitoring System Sales and Revenue by Type (2020-2031)
7.4 Europe Wearable Continuous Glucose Monitoring System Sales and Revenue by Sales Channel (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Wearable Continuous Glucose Monitoring System Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Wearable Continuous Glucose Monitoring System Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Wearable Continuous Glucose Monitoring System Sales and Revenue by Sales Channel (2020-2031)
8.5 Asia-Pacific Wearable Continuous Glucose Monitoring System Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Wearable Continuous Glucose Monitoring System Sales and Revenue by Type (2020-2031)
9.4 Central and South America Wearable Continuous Glucose Monitoring System Sales and Revenue by Sales Channel (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Wearable Continuous Glucose Monitoring System Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Wearable Continuous Glucose Monitoring System Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Wearable Continuous Glucose Monitoring System Sales and Revenue by Sales Channel (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Wearable Continuous Glucose Monitoring System Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Dexcom
11.1.1 Dexcom Corporation Information
11.1.2 Dexcom Business Overview
11.1.3 Dexcom Wearable Continuous Glucose Monitoring System Product Models, Descriptions and Specifications
11.1.4 Dexcom Wearable Continuous Glucose Monitoring System Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Dexcom Wearable Continuous Glucose Monitoring System Sales by Product in 2024
11.1.6 Dexcom Wearable Continuous Glucose Monitoring System Sales by Sales Channel in 2024
11.1.7 Dexcom Wearable Continuous Glucose Monitoring System Sales by Geographic Area in 2024
11.1.8 Dexcom Wearable Continuous Glucose Monitoring System SWOT Analysis
11.1.9 Dexcom Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Business Overview
11.2.3 Abbott Wearable Continuous Glucose Monitoring System Product Models, Descriptions and Specifications
11.2.4 Abbott Wearable Continuous Glucose Monitoring System Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Abbott Wearable Continuous Glucose Monitoring System Sales by Product in 2024
11.2.6 Abbott Wearable Continuous Glucose Monitoring System Sales by Sales Channel in 2024
11.2.7 Abbott Wearable Continuous Glucose Monitoring System Sales by Geographic Area in 2024
11.2.8 Abbott Wearable Continuous Glucose Monitoring System SWOT Analysis
11.2.9 Abbott Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Wearable Continuous Glucose Monitoring System Product Models, Descriptions and Specifications
11.3.4 Medtronic Wearable Continuous Glucose Monitoring System Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Medtronic Wearable Continuous Glucose Monitoring System Sales by Product in 2024
11.3.6 Medtronic Wearable Continuous Glucose Monitoring System Sales by Sales Channel in 2024
11.3.7 Medtronic Wearable Continuous Glucose Monitoring System Sales by Geographic Area in 2024
11.3.8 Medtronic Wearable Continuous Glucose Monitoring System SWOT Analysis
11.3.9 Medtronic Recent Developments
11.4 Senseonics Holdings
11.4.1 Senseonics Holdings Corporation Information
11.4.2 Senseonics Holdings Business Overview
11.4.3 Senseonics Holdings Wearable Continuous Glucose Monitoring System Product Models, Descriptions and Specifications
11.4.4 Senseonics Holdings Wearable Continuous Glucose Monitoring System Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Senseonics Holdings Wearable Continuous Glucose Monitoring System Sales by Product in 2024
11.4.6 Senseonics Holdings Wearable Continuous Glucose Monitoring System Sales by Sales Channel in 2024
11.4.7 Senseonics Holdings Wearable Continuous Glucose Monitoring System Sales by Geographic Area in 2024
11.4.8 Senseonics Holdings Wearable Continuous Glucose Monitoring System SWOT Analysis
11.4.9 Senseonics Holdings Recent Developments
11.5 Handan Meiqi Medical Technology
11.5.1 Handan Meiqi Medical Technology Corporation Information
11.5.2 Handan Meiqi Medical Technology Business Overview
11.5.3 Handan Meiqi Medical Technology Wearable Continuous Glucose Monitoring System Product Models, Descriptions and Specifications
11.5.4 Handan Meiqi Medical Technology Wearable Continuous Glucose Monitoring System Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Handan Meiqi Medical Technology Wearable Continuous Glucose Monitoring System Sales by Product in 2024
11.5.6 Handan Meiqi Medical Technology Wearable Continuous Glucose Monitoring System Sales by Sales Channel in 2024
11.5.7 Handan Meiqi Medical Technology Wearable Continuous Glucose Monitoring System Sales by Geographic Area in 2024
11.5.8 Handan Meiqi Medical Technology Wearable Continuous Glucose Monitoring System SWOT Analysis
11.5.9 Handan Meiqi Medical Technology Recent Developments
11.6 San Meditech
11.6.1 San Meditech Corporation Information
11.6.2 San Meditech Business Overview
11.6.3 San Meditech Wearable Continuous Glucose Monitoring System Product Models, Descriptions and Specifications
11.6.4 San Meditech Wearable Continuous Glucose Monitoring System Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 San Meditech Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Wearable Continuous Glucose Monitoring System Industry Chain
12.2 Wearable Continuous Glucose Monitoring System Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Wearable Continuous Glucose Monitoring System Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Wearable Continuous Glucose Monitoring System Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Wearable Continuous Glucose Monitoring System Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Wearable Continuous Glucose Monitoring System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Wearable Continuous Glucose Monitoring System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Wearable Continuous Glucose Monitoring System Market Size Growth Rate by Sales Channel, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Wearable Continuous Glucose Monitoring System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Wearable Continuous Glucose Monitoring System Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Wearable Continuous Glucose Monitoring System Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Wearable Continuous Glucose Monitoring System Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Wearable Continuous Glucose Monitoring System Sales by Region (2020-2025) & (K Units)
 Table 8. Global Wearable Continuous Glucose Monitoring System Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Wearable Continuous Glucose Monitoring System Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Wearable Continuous Glucose Monitoring System Sales Share by Manufacturers (2020-2025)
 Table 12. Global Wearable Continuous Glucose Monitoring System Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Wearable Continuous Glucose Monitoring System Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Wearable Continuous Glucose Monitoring System by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wearable Continuous Glucose Monitoring System as of 2024)
 Table 16. Global Wearable Continuous Glucose Monitoring System Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Wearable Continuous Glucose Monitoring System Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Wearable Continuous Glucose Monitoring System Manufacturing Base and Headquarters
 Table 19. Global Wearable Continuous Glucose Monitoring System Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Wearable Continuous Glucose Monitoring System Sales by Type (2020-2025) & (K Units)
 Table 23. Global Wearable Continuous Glucose Monitoring System Sales by Type (2026-2031) & (K Units)
 Table 24. Global Wearable Continuous Glucose Monitoring System Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Wearable Continuous Glucose Monitoring System Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Wearable Continuous Glucose Monitoring System ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Wearable Continuous Glucose Monitoring System Sales by Sales Channel (2020-2025) & (K Units)
 Table 29. Global Wearable Continuous Glucose Monitoring System Sales by Sales Channel (2026-2031) & (K Units)
 Table 30. Wearable Continuous Glucose Monitoring System High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Wearable Continuous Glucose Monitoring System Revenue by Sales Channel (2020-2025) & (US$ Million)
 Table 32. Global Wearable Continuous Glucose Monitoring System Revenue by Sales Channel (2026-2031) & (US$ Million)
 Table 33. Global Wearable Continuous Glucose Monitoring System ASP by Sales Channel (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Sales Channel
 Table 36. North America Wearable Continuous Glucose Monitoring System Growth Accelerators and Market Barriers
 Table 37. North America Wearable Continuous Glucose Monitoring System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Wearable Continuous Glucose Monitoring System Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Wearable Continuous Glucose Monitoring System Growth Accelerators and Market Barriers
 Table 40. Europe Wearable Continuous Glucose Monitoring System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Wearable Continuous Glucose Monitoring System Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Wearable Continuous Glucose Monitoring System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Wearable Continuous Glucose Monitoring System Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Wearable Continuous Glucose Monitoring System Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Wearable Continuous Glucose Monitoring System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Wearable Continuous Glucose Monitoring System Investment Opportunities and Key Challenges
 Table 47. Central and South America Wearable Continuous Glucose Monitoring System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Wearable Continuous Glucose Monitoring System Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Wearable Continuous Glucose Monitoring System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Dexcom Corporation Information
 Table 51. Dexcom Description and Major Businesses
 Table 52. Dexcom Product Models, Descriptions and Specifications
 Table 53. Dexcom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Dexcom Sales Value Proportion by Product in 2024
 Table 55. Dexcom Sales Value Proportion by Sales Channel in 2024
 Table 56. Dexcom Sales Value Proportion by Geographic Area in 2024
 Table 57. Dexcom Wearable Continuous Glucose Monitoring System SWOT Analysis
 Table 58. Dexcom Recent Developments
 Table 59. Abbott Corporation Information
 Table 60. Abbott Description and Major Businesses
 Table 61. Abbott Product Models, Descriptions and Specifications
 Table 62. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Abbott Sales Value Proportion by Product in 2024
 Table 64. Abbott Sales Value Proportion by Sales Channel in 2024
 Table 65. Abbott Sales Value Proportion by Geographic Area in 2024
 Table 66. Abbott Wearable Continuous Glucose Monitoring System SWOT Analysis
 Table 67. Abbott Recent Developments
 Table 68. Medtronic Corporation Information
 Table 69. Medtronic Description and Major Businesses
 Table 70. Medtronic Product Models, Descriptions and Specifications
 Table 71. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Medtronic Sales Value Proportion by Product in 2024
 Table 73. Medtronic Sales Value Proportion by Sales Channel in 2024
 Table 74. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 75. Medtronic Wearable Continuous Glucose Monitoring System SWOT Analysis
 Table 76. Medtronic Recent Developments
 Table 77. Senseonics Holdings Corporation Information
 Table 78. Senseonics Holdings Description and Major Businesses
 Table 79. Senseonics Holdings Product Models, Descriptions and Specifications
 Table 80. Senseonics Holdings Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Senseonics Holdings Sales Value Proportion by Product in 2024
 Table 82. Senseonics Holdings Sales Value Proportion by Sales Channel in 2024
 Table 83. Senseonics Holdings Sales Value Proportion by Geographic Area in 2024
 Table 84. Senseonics Holdings Wearable Continuous Glucose Monitoring System SWOT Analysis
 Table 85. Senseonics Holdings Recent Developments
 Table 86. Handan Meiqi Medical Technology Corporation Information
 Table 87. Handan Meiqi Medical Technology Description and Major Businesses
 Table 88. Handan Meiqi Medical Technology Product Models, Descriptions and Specifications
 Table 89. Handan Meiqi Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Handan Meiqi Medical Technology Sales Value Proportion by Product in 2024
 Table 91. Handan Meiqi Medical Technology Sales Value Proportion by Sales Channel in 2024
 Table 92. Handan Meiqi Medical Technology Sales Value Proportion by Geographic Area in 2024
 Table 93. Handan Meiqi Medical Technology Wearable Continuous Glucose Monitoring System SWOT Analysis
 Table 94. Handan Meiqi Medical Technology Recent Developments
 Table 95. San Meditech Corporation Information
 Table 96. San Meditech Description and Major Businesses
 Table 97. San Meditech Product Models, Descriptions and Specifications
 Table 98. San Meditech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. San Meditech Recent Developments
 Table 100. Key Raw Materials Distribution
 Table 101. Raw Materials Key Suppliers
 Table 102. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 103. Milestones in Production Technology Evolution
 Table 104. Distributors List
 Table 105. Market Trends and Market Evolution
 Table 106. Market Drivers and Opportunities
 Table 107. Market Challenges, Risks, and Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources


List of Figures
 Figure 1. Wearable Continuous Glucose Monitoring System Product Picture
 Figure 2. Global Wearable Continuous Glucose Monitoring System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. SMD Type Product Picture
 Figure 4. Watch Type Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Wearable Continuous Glucose Monitoring System Market Size Growth Rate by Sales Channel, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. On-Line
 Figure 8. Offline
 Figure 9. Wearable Continuous Glucose Monitoring System Report Years Considered
 Figure 10. Global Wearable Continuous Glucose Monitoring System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Wearable Continuous Glucose Monitoring System Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Wearable Continuous Glucose Monitoring System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Wearable Continuous Glucose Monitoring System Revenue Market Share by Region (2020-2031)
 Figure 14. Global Wearable Continuous Glucose Monitoring System Sales (2020-2031) & (K Units)
 Figure 15. Global Wearable Continuous Glucose Monitoring System Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global Wearable Continuous Glucose Monitoring System Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Wearable Continuous Glucose Monitoring System Sales Volume Market Share in 2024
 Figure 18. Global Wearable Continuous Glucose Monitoring System Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. SMD Type Revenue Market Share by Manufacturer in 2024
 Figure 21. Watch Type Revenue Market Share by Manufacturer in 2024
 Figure 22. Others Revenue Market Share by Manufacturer in 2024
 Figure 23. Global Wearable Continuous Glucose Monitoring System Sales Market Share by Type (2020-2031)
 Figure 24. Global Wearable Continuous Glucose Monitoring System Revenue Market Share by Type (2020-2031)
 Figure 25. Global Wearable Continuous Glucose Monitoring System Sales Market Share by Sales Channel (2020-2031)
 Figure 26. Global Wearable Continuous Glucose Monitoring System Revenue Market Share by Sales Channel (2020-2031)
 Figure 27. North America Wearable Continuous Glucose Monitoring System Sales YoY (2020-2031) & (K Units)
 Figure 28. North America Wearable Continuous Glucose Monitoring System Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Manufacturers Wearable Continuous Glucose Monitoring System Sales Revenue (US$ Million) in 2024
 Figure 30. North America Wearable Continuous Glucose Monitoring System Sales Volume (K Units) by Type (2020- 2031)
 Figure 31. North America Wearable Continuous Glucose Monitoring System Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 32. North America Wearable Continuous Glucose Monitoring System Sales Volume (K Units) by Sales Channel (2020-2031)
 Figure 33. North America Wearable Continuous Glucose Monitoring System Sales Revenue (US$ Million) by Sales Channel (2020-2031)
 Figure 34. US Wearable Continuous Glucose Monitoring System Revenue (2020-2031) & (US$ Million)
 Figure 35. Canada Wearable Continuous Glucose Monitoring System Revenue (2020-2031) & (US$ Million)
 Figure 36. Mexico Wearable Continuous Glucose Monitoring System Revenue (2020-2031) & (US$ Million)
 Figure 37. Europe Wearable Continuous Glucose Monitoring System Sales YoY (2020-2031) & (K Units)
 Figure 38. Europe Wearable Continuous Glucose Monitoring System Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Europe Top 5 Manufacturers Wearable Continuous Glucose Monitoring System Sales Revenue (US$ Million) in 2024
 Figure 40. Europe Wearable Continuous Glucose Monitoring System Sales Volume (K Units) by Type (2020-2031)
 Figure 41. Europe Wearable Continuous Glucose Monitoring System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Europe Wearable Continuous Glucose Monitoring System Sales Volume (K Units) by Sales Channel (2020-2031)
 Figure 43. Europe Wearable Continuous Glucose Monitoring System Sales Revenue (US$ Million) by Sales Channel (2020-2031)
 Figure 44. Germany Wearable Continuous Glucose Monitoring System Revenue (2020-2031) & (US$ Million)
 Figure 45. France Wearable Continuous Glucose Monitoring System Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. Wearable Continuous Glucose Monitoring System Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy Wearable Continuous Glucose Monitoring System Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia Wearable Continuous Glucose Monitoring System Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Wearable Continuous Glucose Monitoring System Sales YoY (2020-2031) & (K Units)
 Figure 50. Asia-Pacific Wearable Continuous Glucose Monitoring System Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Top 8 Manufacturers Wearable Continuous Glucose Monitoring System Sales Revenue (US$ Million) in 2024
 Figure 52. Asia-Pacific Wearable Continuous Glucose Monitoring System Sales Volume (K Units) by Type (2020- 2031)
 Figure 53. Asia-Pacific Wearable Continuous Glucose Monitoring System Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 54. Asia-Pacific Wearable Continuous Glucose Monitoring System Sales Volume (K Units) by Sales Channel (2020-2031)
 Figure 55. Asia-Pacific Wearable Continuous Glucose Monitoring System Sales Revenue (US$ Million) by Sales Channel (2020-2031)
 Figure 56. Indonesia Wearable Continuous Glucose Monitoring System Revenue (2020-2031) & (US$ Million)
 Figure 57. Japan Wearable Continuous Glucose Monitoring System Revenue (2020-2031) & (US$ Million)
 Figure 58. South Korea Wearable Continuous Glucose Monitoring System Revenue (2020-2031) & (US$ Million)
 Figure 59. China Taiwan Wearable Continuous Glucose Monitoring System Revenue (2020-2031) & (US$ Million)
 Figure 60. India Wearable Continuous Glucose Monitoring System Revenue (2020-2031) & (US$ Million)
 Figure 61. Central and South America Wearable Continuous Glucose Monitoring System Sales YoY (2020-2031) & (K Units)
 Figure 62. Central and South America Wearable Continuous Glucose Monitoring System Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Central and South America Top 5 Manufacturers Wearable Continuous Glucose Monitoring System Sales Revenue (US$ Million) in 2024
 Figure 64. Central and South America Wearable Continuous Glucose Monitoring System Sales Volume (K Units) by Type (2021-2031)
 Figure 65. Central and South America Wearable Continuous Glucose Monitoring System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Central and South America Wearable Continuous Glucose Monitoring System Sales Volume (K Units) by Sales Channel (2020-2031)
 Figure 67. Central and South America Wearable Continuous Glucose Monitoring System Sales Revenue (US$ Million) by Sales Channel (2020-2031)
 Figure 68. Brazil Wearable Continuous Glucose Monitoring System Revenue (2020-2025) & (US$ Million)
 Figure 69. Argentina Wearable Continuous Glucose Monitoring System Revenue (2020-2025) & (US$ Million)
 Figure 70. Middle East, and Africa Wearable Continuous Glucose Monitoring System Sales YoY (2020-2031) & (K Units)
 Figure 71. Middle East and Africa Wearable Continuous Glucose Monitoring System Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Middle East and Africa Top 5 Manufacturers Wearable Continuous Glucose Monitoring System Sales Revenue (US$ Million) in 2024
 Figure 73. Middle East and Africa Wearable Continuous Glucose Monitoring System Sales Volume (K Units) by Type (2021-2031)
 Figure 74. South America Wearable Continuous Glucose Monitoring System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Middle East and Africa Wearable Continuous Glucose Monitoring System Sales Volume (K Units) by Sales Channel (2020-2031)
 Figure 76. Middle East and Africa Wearable Continuous Glucose Monitoring System Sales Revenue (US$ Million) by Sales Channel (2020-2031)
 Figure 77. GCC Countries Wearable Continuous Glucose Monitoring System Revenue (2020-2025) & (US$ Million)
 Figure 78. Turkey Wearable Continuous Glucose Monitoring System Revenue (2020-2025) & (US$ Million)
 Figure 79. Egypt Wearable Continuous Glucose Monitoring System Revenue (2020-2025) & (US$ Million)
 Figure 80. South Africa Wearable Continuous Glucose Monitoring System Revenue (2020-2025) & (US$ Million)
 Figure 81. Wearable Continuous Glucose Monitoring System Industry Chain Mapping
 Figure 82. Regional Wearable Continuous Glucose Monitoring System Manufacturing Base Distribution (%)
 Figure 83. Global Wearable Continuous Glucose Monitoring System Production Market Share by Region (2020-2031)
 Figure 84. Wearable Continuous Glucose Monitoring System Production Process
 Figure 85. Regional Wearable Continuous Glucose Monitoring System Production Cost Structure
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS